4-Benzyl 1-tert-butyl piperidine-1,4-dicarboxylate, 95.0%, 1g

3-Phosphonobenzoic Acid>98.0%(HPLC)(T)200mg

Methyl (2-imino-1,3-thiazolidin-3-yl)acetate hydrobromide, 95.0%, 250mg

Methyl 3-(2-fluorophenyl)-2,2-dimethylpropanoate, 5g

(S)-Ethyl 3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate, 95%, 5g

1-(Tert-butyl)-5-methyl-1h-pyrazol-3-amine, 97%, 250mg

METHYL (1R,3S)-3-HYDROXYCYCLOHEXANE-1-CARBOXYLATE, 95.0%, 1g

4'-chloro-3'-fluoro-3-(4-methoxyphenyl)propiophenone, 97.0%, 1g

CLONIXIN, 95%, 5g

Incubadora Heratherm Protocol series Protocolo general con convección natural, 194 l, IGS180, 1 pieza

(E)-1,1,4,4-tetramethoxybut-2-ene, 90+%, 1g

Ethyl 6-(piperidin-1-yl)pyridine-3-carboxylate, 98%, 1g

4-Bromo-2-methyl-2H-pyrazolo[3,4-c]pyridine, 97%, 1g